Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

122 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL

NCT04883749

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Hanusch Krankenhaus Vienna, Austria
  • Onkologische Schwerpunktpraxis Kurfürstendamm Berlin, Germany
  • Universitätsklinik Köln Cologne, Germany
View all 20 locations
View Trial Details
Completed

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

NCT00788684

Conditions
CD20-Positive Lymphoid Malignancies, Chronic Lymphoid Leukemia, Hematologic Diseases, +16 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 16721 Tucson, Arizona, United States
  • Stanford University School of Med /ID# 9782 Stanford, California, United States
  • Cleveland Clinic Main Campus /ID# 9784 Cleveland, Ohio, United States
  • Univ of Wisconsin Hosp/Clinics /ID# 21701 Madison, Wisconsin, United States
View Trial Details
Completed

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

NCT04716075

Conditions
Adverse Event, Bronchial Diseases, Bronchiolitis, +33 more
Locations
  • Szpital Kliniczny Przemienienia Pańskiego, Oddział Hematologii i Transplantacji Szpiku Poznan, Greater Poland Voivodeship, Poland
  • Instytut Hematologii i Transfuzjologii Warsaw, Masovian Voivodeship, Poland
  • Narodowy Intytut Onkologii im. M. Skłodowskiej-Curie Oddział w Krakowie, Pododdział Leczenia Nowotworów Układu Chłonnego Krakow, Małopolska, Poland
  • Klinika Transplantacji Szpiku i Onkohematologii; Centrum Onkologii Instytut im. M.Sklodowskiej-Curie, Oddz. w Gliwicach Gliwice, Silesian Voivodeship, Poland
View Trial Details
Completed

Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients With Relapsed/Refractory CLL

NCT03787264

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Universitätsklinik Köln Cologne, Germany
  • Gemeinschaftspraxis Hämatologie Onkologie Dresden, Germany
  • Gemeinschaftspraxis Mohm/Prange-Krex Dresden, Germany
  • Universitatsklinik Carl Gustav Carus Dresden, Germany
View all 17 locations
View Trial Details
Completed

Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma

NCT02920697

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services Melbourne, Australia
  • Hopital Claude Huriez Lille, France
  • CHU de Nantes Nantes, France
  • Centre hospitalier Lyon Sud Pierre-Bénite, France
View all 18 locations
View Trial Details
Completed

Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers

NCT01597219

Conditions
Acquired Bone Marrow Failure Syndromes, Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, +33 more
Locations
  • Birmingham Heartlands Birmingham, United Kingdom
  • Bristol Royal Infirmary Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • Beatson Hospital Glasgow, United Kingdom
View Trial Details
Completed

A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

NCT01063907

Conditions
Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +28 more
Locations
  • Arizona Clinical Research Center, Inc. / Arizona Oncology Associates, 1825 N Kolb, Tucson, Arizona, United States
  • Pacific Shores Medical Group 1043 Elm Ave, Suite 104 Long Beach, California, United States
  • UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, Los Angeles, California, United States
  • Collaborative Research Group 2320 S Seacrest Blvd, Suite 202 Boynton Beach, Florida, United States
View all 26 locations
View Trial Details
Completed

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

NCT00457782

Conditions
B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, Bronchial Diseases, +31 more
Locations
  • St Bartholomew's Hospital London, United Kingdom
  • UCLH London, United Kingdom
  • Christie Hospital Manchester, United Kingdom
  • Nottingham University NHS Trust Nottingham, United Kingdom
View Trial Details

Related conditions